Loading...
A joint test for progression and survival with interval-censored data from a cancer clinical trial
Clinical trials often assess efficacy by comparing treatments on the basis of two or more event-time outcomes. In the case of cancer clinical trials, progression-free survival (PFS), which is the minimum of the time from randomization to progression or to death, summarizes the comparison of treatmen...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2014
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4112954/ https://ncbi.nlm.nih.gov/pubmed/24500790 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/sim.6096 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|